☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Metastatic Castration Resistant Prostate Cancer
Ubix Therapeutics Collaborates with Yuhan to Develop UBX-103 for Treating Metastatic Castration Resistant Prostate Cancer
July 2, 2024
Novartis’ Pluvicto Receives EC's Approval for Progressive PSMA+ Metastatic Castration Resistant Prostate Cancer
December 13, 2022
Full-Life Technologies Signed an Agreement to Acquire Focus-X Therapeutics to Advance Peptide-Focused Radiopharmaceutical Pipeline
November 29, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.